echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > Rubber Plastic News > $210 million!

    $210 million!

    • Last Update: 2022-08-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Evonik announced the acquisition of the US Porocel Group for US$210 million to accelerate the growth of the catalyst business


    .



    "This acquisition is an important step in the development strategy of Evonik's product portfolio .


    Evonik said that Porocel's global presence will help enhance the global influence of Evonik's catalyst business


    .


    drive sustainable development 

    Claus Rettig, head of Evonik's smart materials business unit, said that the acquisition will help Evonik to practice sustainable development


    .


    “Sustainability, especially the circular economy, is one of our biggest considerations when it comes to acquisitions and product portfolio positioning.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.